JP2007524670A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007524670A5 JP2007524670A5 JP2006551000A JP2006551000A JP2007524670A5 JP 2007524670 A5 JP2007524670 A5 JP 2007524670A5 JP 2006551000 A JP2006551000 A JP 2006551000A JP 2006551000 A JP2006551000 A JP 2006551000A JP 2007524670 A5 JP2007524670 A5 JP 2007524670A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- pharmaceutically acceptable
- acceptable salt
- carbocyclyl
- heterocyclyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 CC(C)c1cc(-c2c[s]c(*)n2)nc2c1cccc2 Chemical compound CC(C)c1cc(-c2c[s]c(*)n2)nc2c1cccc2 0.000 description 1
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0400199A SE0400199D0 (sv) | 2004-01-30 | 2004-01-30 | HCV Protease inhbitors |
| SE0400199-6 | 2004-01-30 | ||
| SE0401288-6 | 2004-05-19 | ||
| SE0401288A SE0401288D0 (sv) | 2004-05-19 | 2004-05-19 | HCV NS-3 Serine Protease Inhbitors |
| SE0402562-3 | 2004-10-22 | ||
| SE0402562A SE0402562D0 (sv) | 2004-10-22 | 2004-10-22 | HCV Protease Inhbitors |
| PCT/SE2005/000096 WO2005073216A2 (en) | 2004-01-30 | 2005-01-28 | Hcv ns-3 serine protease inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007524670A JP2007524670A (ja) | 2007-08-30 |
| JP2007524670A5 true JP2007524670A5 (https=) | 2012-04-12 |
| JP5248783B2 JP5248783B2 (ja) | 2013-07-31 |
Family
ID=34831013
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006551001A Expired - Fee Related JP4902361B2 (ja) | 2004-01-30 | 2005-01-28 | Ｈｃｖｎｓ−３セリンプロテアーゼインヒビター |
| JP2006551000A Expired - Fee Related JP5248783B2 (ja) | 2004-01-30 | 2005-01-28 | Ｈｃｖｎｓ−３セリンプロテアーゼインヒビター |
| JP2010279178A Pending JP2011140488A (ja) | 2004-01-30 | 2010-12-15 | Ｈｃｖｎｓ−３セリンプロテアーゼインヒビター |
| JP2013234011A Expired - Fee Related JP5795619B2 (ja) | 2004-01-30 | 2013-11-12 | Ｈｃｖｎｓ−３セリンプロテアーゼインヒビター |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006551001A Expired - Fee Related JP4902361B2 (ja) | 2004-01-30 | 2005-01-28 | Ｈｃｖｎｓ−３セリンプロテアーゼインヒビター |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010279178A Pending JP2011140488A (ja) | 2004-01-30 | 2010-12-15 | Ｈｃｖｎｓ−３セリンプロテアーゼインヒビター |
| JP2013234011A Expired - Fee Related JP5795619B2 (ja) | 2004-01-30 | 2013-11-12 | Ｈｃｖｎｓ−３セリンプロテアーゼインヒビター |
Country Status (32)
| Country | Link |
|---|---|
| US (5) | US7671032B2 (https=) |
| EP (2) | EP1713822B1 (https=) |
| JP (4) | JP4902361B2 (https=) |
| KR (3) | KR20120090077A (https=) |
| AR (2) | AR048401A1 (https=) |
| AT (2) | ATE448243T1 (https=) |
| AU (2) | AU2005207815B2 (https=) |
| BR (2) | BRPI0506948B1 (https=) |
| CA (2) | CA2552319C (https=) |
| CR (2) | CR8539A (https=) |
| CY (1) | CY1109779T1 (https=) |
| DE (2) | DE602005017582D1 (https=) |
| DK (2) | DK1713822T3 (https=) |
| EA (2) | EA012410B1 (https=) |
| EC (2) | ECSP066725A (https=) |
| ES (2) | ES2336009T3 (https=) |
| HR (1) | HRP20100048T1 (https=) |
| IL (2) | IL176848A (https=) |
| LU (1) | LU92595I2 (https=) |
| MY (2) | MY153011A (https=) |
| NI (1) | NI200600168A (https=) |
| NL (1) | NL300703I2 (https=) |
| NO (1) | NO341392B1 (https=) |
| NZ (2) | NZ548740A (https=) |
| PL (2) | PL1713823T3 (https=) |
| PT (1) | PT1713823E (https=) |
| RS (1) | RS51243B (https=) |
| SI (1) | SI1713823T1 (https=) |
| TW (2) | TWI361195B (https=) |
| UA (2) | UA84050C2 (https=) |
| WO (2) | WO2005073195A2 (https=) |
| ZA (1) | ZA200607214B (https=) |
Families Citing this family (124)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY140680A (en) | 2002-05-20 | 2010-01-15 | Bristol Myers Squibb Co | Hepatitis c virus inhibitors |
| US7176208B2 (en) | 2003-04-18 | 2007-02-13 | Enanta Pharmaceuticals, Inc. | Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors |
| CL2004001161A1 (es) * | 2003-05-21 | 2005-04-08 | Boehringer Ingelheim Int | Compuestos describe compuestos derivados de quinolina; composicion farmaceutica; y su uso para tratar una enfermedad causada por el virus de la hepatitis c. |
| US7491794B2 (en) * | 2003-10-14 | 2009-02-17 | Intermune, Inc. | Macrocyclic compounds as inhibitors of viral replication |
| JP4902361B2 (ja) | 2004-01-30 | 2012-03-21 | メディヴィル・アクチエボラーグ | Ｈｃｖｎｓ−３セリンプロテアーゼインヒビター |
| AP2006003763A0 (en) * | 2004-03-30 | 2006-10-31 | Intermune Inc | Macrocyclic compounds as inhibitors of viral replication |
| US7323447B2 (en) | 2005-02-08 | 2008-01-29 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| US7592336B2 (en) | 2005-05-10 | 2009-09-22 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| US7601686B2 (en) | 2005-07-11 | 2009-10-13 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| MX2008001166A (es) | 2005-07-25 | 2008-03-18 | Intermune Inc | Nuevos inhibidores macrociclicos de la replicacion del virus de hepatitis c. |
| JP5230416B2 (ja) | 2005-07-29 | 2013-07-10 | テイボテク・フアーマシユーチカルズ | Ｃ型肝炎ウイルスの大員環状阻害剤 |
| WO2007014922A1 (en) * | 2005-07-29 | 2007-02-08 | Tibotec Pharmaceuticals Ltd. | Macrocyclic inhibitors of hepatitis c virus |
| TWI393723B (zh) | 2005-07-29 | 2013-04-21 | Tibotec Pharm Ltd | Ｃ型肝炎病毒之大環抑制劑（九） |
| JO2768B1 (en) | 2005-07-29 | 2014-03-15 | تيبوتيك فارماسيوتيكالز ليمتد | Large cyclic inhibitors of hepatitis C virus |
| CN101273042B (zh) * | 2005-07-29 | 2013-11-06 | 泰博特克药品有限公司 | 丙型肝炎病毒的大环抑制剂 |
| PE20070343A1 (es) * | 2005-07-29 | 2007-05-12 | Medivir Ab | Inhibidores macrociclicos del virus de la hepatitis c |
| US7700552B2 (en) * | 2005-07-29 | 2010-04-20 | Medivir Ab | Macrocyclic inhibitors of hepatitis C virus |
| PE20070211A1 (es) * | 2005-07-29 | 2007-05-12 | Medivir Ab | Compuestos macrociclicos como inhibidores del virus de hepatitis c |
| ES2373685T3 (es) | 2005-07-29 | 2012-02-07 | Tibotec Pharmaceuticals | Inhibidores macrocíclicos del virus de la hepatitis c. |
| CA2617099C (en) * | 2005-07-29 | 2014-03-25 | Tibotec Pharmaceuticals Ltd. | Macrocyclic inhibitors of hepatitis c virus |
| PE20070210A1 (es) * | 2005-07-29 | 2007-04-16 | Tibotec Pharm Ltd | Compuestos macrociclicos como inhibidores del virus de hepatitis c |
| UA95239C2 (ru) * | 2005-07-29 | 2011-07-25 | Тиботек Фармасьютикелз Лтд. | Макроциклические ингибиторы вируса гепатита с |
| AR055395A1 (es) | 2005-08-26 | 2007-08-22 | Vertex Pharma | Compuestos inhibidores de la actividad de la serina proteasa ns3-ns4a del virus de la hepatitis c |
| AU2006301966A1 (en) | 2005-10-11 | 2007-04-19 | Array Biopharma, Inc. | Compounds and methods for inhibiting hepatitis C viral replication |
| US7772183B2 (en) | 2005-10-12 | 2010-08-10 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| CA2627247C (en) * | 2005-10-28 | 2013-04-02 | Boehringer Ingelheim International Gmbh | Hepatitis c virus ns2/3 activity assay |
| US7741281B2 (en) | 2005-11-03 | 2010-06-22 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| KR20090024834A (ko) * | 2006-07-05 | 2009-03-09 | 인터뮨, 인크. | Ｃ형 간염 바이러스 복제의 신규 억제제 |
| EP2049474B1 (en) | 2006-07-11 | 2015-11-04 | Bristol-Myers Squibb Company | Hepatitis c virus inhibitors |
| NZ574605A (en) | 2006-07-13 | 2011-11-25 | Achillion Pharmaceuticals Inc | 4-amino-4-oxobutanoyl peptides as inhibitors of viral replication |
| EP1881001A1 (en) * | 2006-07-20 | 2008-01-23 | Tibotec Pharmaceuticals Ltd. | HCV NS-3 serine protease inhibitors |
| EP1881002A1 (en) * | 2006-07-20 | 2008-01-23 | Tibotec Pharmaceuticals Ltd. | HCV NS-3 serine protease inhibitors |
| EP2056106B1 (en) * | 2006-08-09 | 2017-10-11 | Sumitomo Bakelite Company, Ltd. | Sugar chain-capturing substance and use thereof |
| AP2009004812A0 (en) | 2006-10-10 | 2009-04-30 | Medivir Ab | HCV nucleoside inhibitor |
| US20120220520A1 (en) * | 2006-10-17 | 2012-08-30 | Van T Klooster Gerben Albert Eleutherius | Bioavailable combinations for hcv treatment |
| US8343477B2 (en) | 2006-11-01 | 2013-01-01 | Bristol-Myers Squibb Company | Inhibitors of hepatitis C virus |
| US7772180B2 (en) | 2006-11-09 | 2010-08-10 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| US7763584B2 (en) | 2006-11-16 | 2010-07-27 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| US7888464B2 (en) | 2006-11-16 | 2011-02-15 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| US8003604B2 (en) | 2006-11-16 | 2011-08-23 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| CA2661338C (en) * | 2006-11-17 | 2015-05-12 | Tibotec Pharmaceuticals Ltd. | Macrocyclic inhibitors of hepatitis c virus |
| EP2121681B1 (en) | 2007-01-11 | 2015-04-15 | Critical Outcome Technologies, Inc. | Compounds and method for treatment of cancer |
| NZ600947A (en) * | 2007-01-26 | 2012-12-21 | Kaneq Pharma Inc | Fused Aromatic Difluoromethanephosphonates as Protein Tyrosine Phosphatase 1B (PTP-1B) Inhibitors |
| AR065137A1 (es) * | 2007-02-01 | 2009-05-20 | Tibotec Pharm Ltd | Procesos e intermediarios para la preparacion de un inhibidor de proteasa macrociclico del vhc y metodos de obtencion de los mencionados intermediarios. |
| BRPI0806945A2 (pt) * | 2007-02-01 | 2014-05-06 | Tibotec Pharm Ltd | Formas polimórficas de um inibidor macrocíclico de hcv |
| BRPI0807087A2 (pt) * | 2007-02-08 | 2014-06-10 | Tibotec Pharm Ltd | Inibidores de hcv macrocíclicos substituídos de pirimidina |
| US8383584B2 (en) * | 2007-02-08 | 2013-02-26 | Medivir Ab | HCV inhibiting macrocyclic phenylcarbamates |
| WO2008106130A2 (en) | 2007-02-26 | 2008-09-04 | Achillion Pharmaceuticals, Inc. | Tertiary amine substituted peptides useful as inhibitors of hcv replication |
| MX2009010207A (es) * | 2007-03-23 | 2009-10-19 | Schering Corp | Peptidos de hidrazido como inhibidores de proteasa ns3 de virus de hepatitis c. |
| WO2008141227A1 (en) | 2007-05-10 | 2008-11-20 | Intermune, Inc. | Novel peptide inhibitors of hepatitis c virus replication |
| WO2009042668A2 (en) | 2007-09-24 | 2009-04-02 | Achillion Pharmaceuticals, Inc. | Urea-containing peptides as inhibitors of viral replication |
| US8419332B2 (en) * | 2007-10-19 | 2013-04-16 | Atlas Bolt & Screw Company Llc | Non-dimpling fastener |
| CN102026544A (zh) * | 2007-11-14 | 2011-04-20 | 益安药业 | 大环四唑基丙型肝炎病毒丝氨酸蛋白酶抑制剂 |
| US8273709B2 (en) | 2007-12-14 | 2012-09-25 | Enanta Pharmaceuticals, Inc. | Triazole-containing macrocyclic HCV serine protease inhibitors |
| US8283309B2 (en) * | 2007-12-20 | 2012-10-09 | Enanta Pharmaceuticals, Inc. | Bridged carbocyclic oxime hepatitis C virus serine protease inhibitors |
| US8202996B2 (en) | 2007-12-21 | 2012-06-19 | Bristol-Myers Squibb Company | Crystalline forms of N-(tert-butoxycarbonyl)-3-methyl-L-valyl-(4R)-4-((7-chloro-4-methoxy-1-isoquinolinyl)oxy)-N- ((1R,2S)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)-L-prolinamide |
| CA2710039C (en) | 2007-12-26 | 2018-07-03 | Critical Outcome Technologies, Inc. | Semicarbazones, thiosemicarbazones and related compounds and methods for treatment of cancer |
| RU2490272C2 (ru) * | 2008-02-04 | 2013-08-20 | Айденикс Фармасьютикалз, Инк. | Макроциклические ингибиторы серинпротеазы |
| WO2009117594A1 (en) | 2008-03-20 | 2009-09-24 | Enanta Pharmaceuticals, Inc. | Fluorinated macrocyclic compounds as hepatitis c virus inhibitors |
| EA201071034A1 (ru) | 2008-04-15 | 2011-06-30 | Интермьюн, Инк. | Новые макроциклические ингибиторы репликаций вируса гепатита с |
| US8163921B2 (en) | 2008-04-16 | 2012-04-24 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| US7964560B2 (en) | 2008-05-29 | 2011-06-21 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| WO2009148923A1 (en) | 2008-05-29 | 2009-12-10 | Bristol-Myers Squibb Company | Hepatitis c virus inhibitors |
| TWI454476B (zh) | 2008-07-08 | 2014-10-01 | Tibotec Pharm Ltd | 用作ｃ型肝炎病毒抑制劑之巨環吲哚衍生物 |
| EP2318406B1 (en) | 2008-07-17 | 2016-01-27 | Critical Outcome Technologies, Inc. | Thiosemicarbazone inhibitor compounds and cancer treatment methods |
| US8207341B2 (en) | 2008-09-04 | 2012-06-26 | Bristol-Myers Squibb Company | Process or synthesizing substituted isoquinolines |
| UY32099A (es) | 2008-09-11 | 2010-04-30 | Enanta Pharm Inc | Inhibidores macrocíclicos de serina proteasas de hepatitis c |
| US8044087B2 (en) | 2008-09-29 | 2011-10-25 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| US8563505B2 (en) | 2008-09-29 | 2013-10-22 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| WO2010065674A1 (en) | 2008-12-03 | 2010-06-10 | Presidio Pharmaceuticals, Inc. | Inhibitors of hcv ns5a |
| CA2750577A1 (en) | 2008-12-03 | 2010-06-10 | Presidio Pharmaceuticals, Inc. | Inhibitors of hcv ns5a |
| EA022134B1 (ru) | 2008-12-10 | 2015-11-30 | Ачиллион Фармасьютикалз, Инк. | 4-амино-4-оксобутаноил-пептиды как ингибиторы репликации вирусов |
| US8283310B2 (en) | 2008-12-15 | 2012-10-09 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| SI2382198T1 (sl) * | 2008-12-23 | 2013-11-29 | Janssen Pharmaceuticals, Inc. | Postopek in vmesne spojine za pripravo makrocikličnega inhibitorja HCV proteaze |
| AR075584A1 (es) | 2009-02-27 | 2011-04-20 | Intermune Inc | COMPOSICIONES TERAPEUTICAS QUE COMPRENDEN beta-D-2'-DESOXI-2'-FLUORO-2'-C-METILCITIDINA Y UN DERIVADO DE ACIDO ISOINDOL CARBOXILICO Y SUS USOS. COMPUESTO. |
| PT2401272T (pt) | 2009-02-27 | 2017-02-28 | Janssen Pharmaceuticals Inc | Sal amorfo de um inibidor macrocíclico de hcv |
| SG174883A1 (en) | 2009-03-27 | 2011-11-28 | Presidio Pharmaceuticals Inc | Fused ring inhibitors of hepatitis c |
| WO2010118078A1 (en) | 2009-04-08 | 2010-10-14 | Idenix Pharmaceuticals, Inc. | Macrocyclic serine protease inhibitors |
| TW201117812A (en) | 2009-08-05 | 2011-06-01 | Idenix Pharmaceuticals Inc | Macrocyclic serine protease inhibitors |
| WO2011112516A1 (en) | 2010-03-08 | 2011-09-15 | Ico Therapeutics Inc. | Treating and preventing hepatitis c virus infection using c-raf kinase antisense oligonucleotides |
| AU2011229164B2 (en) | 2010-03-16 | 2015-11-26 | Janssen Pharmaceuticals, Inc. | Processes and intermediates for preparing a macrocyclic protease inhibitor of HCV |
| EP2552915B1 (en) | 2010-04-01 | 2017-07-19 | Critical Outcome Technologies Inc. | Compounds for the treatment of hiv |
| CA2796243A1 (en) | 2010-04-13 | 2011-10-20 | Janssen Pharmaceuticals, Inc. | Combination of a macrocyclic inhibitor of hcv, a non-nucleoside and a nucleoside |
| WO2011149856A1 (en) | 2010-05-24 | 2011-12-01 | Presidio Pharmaceuticals, Inc. | Inhibitors of hcv ns5a |
| AR082619A1 (es) | 2010-08-13 | 2012-12-19 | Hoffmann La Roche | Inhibidores del virus de la hepatitis c |
| SG189985A1 (en) | 2010-10-26 | 2013-06-28 | Presidio Pharmaceuticals Inc | Inhibitors of hepatitis c virus |
| MX2013004906A (es) | 2010-11-01 | 2013-12-06 | Genoscience Pharma | Nuevos inhibidores especificos de la proteasa ns3 de hcv. |
| EA201390988A1 (ru) | 2010-12-30 | 2014-04-30 | Энанта Фармасьютикалз, Инк. | Фенантридиновые макроциклические ингибиторы сериновой протеазы вируса гепатита c |
| CA2822556A1 (en) | 2010-12-30 | 2012-07-05 | Enanta Pharmaceuticals, Inc | Macrocyclic hepatitis c serine protease inhibitors |
| US9353100B2 (en) | 2011-02-10 | 2016-05-31 | Idenix Pharmaceuticals Llc | Macrocyclic serine protease inhibitors, pharmaceutical compositions thereof, and their use for treating HCV infections |
| WO2012123298A1 (en) | 2011-03-11 | 2012-09-20 | F. Hoffmann-La Roche Ag | Antiviral compounds |
| US8957203B2 (en) | 2011-05-05 | 2015-02-17 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| US10201584B1 (en) | 2011-05-17 | 2019-02-12 | Abbvie Inc. | Compositions and methods for treating HCV |
| US8691757B2 (en) | 2011-06-15 | 2014-04-08 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| BR112013032188A2 (pt) | 2011-06-23 | 2016-12-20 | Digna Biotech Sl | composição, produto e método para tratar pacientes com hepatite c crônica |
| US20120328565A1 (en) | 2011-06-24 | 2012-12-27 | Brinkman John A | Antiviral compounds |
| CN107011339A (zh) | 2011-09-22 | 2017-08-04 | 杨森制药公司 | 用于制备hcv的大环蛋白酶抑制剂的方法和中间体 |
| RU2014117587A (ru) | 2011-10-10 | 2015-11-20 | Ф. Хоффманн-Ля Рош Аг | Противовирусные соединения |
| KR20140104030A (ko) | 2011-12-16 | 2014-08-27 | 에프. 호프만-라 로슈 아게 | Hcv ns5a의 억제제 |
| AU2012357940B2 (en) | 2011-12-20 | 2017-02-16 | Riboscience Llc | 2',4'-difluoro-2'-methyl substituted nucleoside derivatives as inhibitors of HCV RNA replication |
| MX350810B (es) | 2011-12-20 | 2017-09-20 | Riboscience Llc | Derivados de los nucleosidos sustituidos en 4 '-azido, 3 '-fluoro como inhibidores de la replicacion del rna del vhc. |
| US9040479B2 (en) | 2012-01-12 | 2015-05-26 | Cocrystal Pharma, Inc. | HCV NS3 protease inhibitors |
| JP6092261B2 (ja) | 2012-02-24 | 2017-03-08 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | 抗ウイルス化合物 |
| US20140010783A1 (en) | 2012-07-06 | 2014-01-09 | Hoffmann-La Roche Inc. | Antiviral compounds |
| EA025560B1 (ru) | 2012-10-19 | 2017-01-30 | Бристол-Майерс Сквибб Компани | Ингибиторы вируса гепатита с |
| US9334279B2 (en) | 2012-11-02 | 2016-05-10 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| EP2914613B1 (en) | 2012-11-02 | 2017-11-22 | Bristol-Myers Squibb Company | Hepatitis c virus inhibitors |
| US9643999B2 (en) | 2012-11-02 | 2017-05-09 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| US9409943B2 (en) | 2012-11-05 | 2016-08-09 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| CN105073726B (zh) | 2013-01-23 | 2017-05-31 | 弗·哈夫曼-拉罗切有限公司 | 抗病毒三唑衍生物 |
| BR112015021429A2 (pt) | 2013-03-05 | 2017-07-18 | Hoffmann La Roche | compostos antivirais |
| JP6342922B2 (ja) | 2013-03-07 | 2018-06-13 | ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ | Ｃ型肝炎ウイルス阻害剤 |
| WO2014152928A2 (en) | 2013-03-14 | 2014-09-25 | Achillion Pharmaceuticals, Inc. | Novel processes for producing sovaprevir |
| US9085607B2 (en) | 2013-03-15 | 2015-07-21 | Achillion Pharmaceuticals, Inc. | ACH-0142684 sodium salt polymorph, composition including the same, and method of manufacture thereof |
| WO2014145507A1 (en) | 2013-03-15 | 2014-09-18 | Achillion Pharmaceuticals, Inc. | A process for making a 4-amino-4-oxobutanoyl peptide cyclic analogue, an inhibitor of viral replication, and intermediates thereof |
| AU2014227849A1 (en) | 2013-03-15 | 2015-10-01 | Achillion Pharmaceuticals, Inc. | Sovaprevir polymorphs and methods of manufacture thereof |
| JP6366693B2 (ja) | 2013-05-16 | 2018-08-01 | リボサイエンス・エルエルシー | ４’−フルオロ−２’−メチル置換ヌクレオシド誘導体 |
| US20180200280A1 (en) | 2013-05-16 | 2018-07-19 | Riboscience Llc | 4'-Fluoro-2'-Methyl Substituted Nucleoside Derivatives as Inhibitors of HCV RNA Replication |
| MA38678A1 (fr) | 2013-05-16 | 2017-07-31 | Riboscience Llc | Dérivés nucléosidiques 4'-azido, 3'désoxy-3'-fluoro substitués |
| WO2015103490A1 (en) | 2014-01-03 | 2015-07-09 | Abbvie, Inc. | Solid antiviral dosage forms |
| EP2899207A1 (en) | 2014-01-28 | 2015-07-29 | Amikana.Biologics | New method for testing HCV protease inhibition |
| AU2018335411B2 (en) | 2017-09-21 | 2024-06-27 | Riboscience Llc | 4'-fluoro-2'-methyl substituted nucleoside derivatives as inhibitors of HCV RNA replication |
| WO2019070979A1 (en) | 2017-10-04 | 2019-04-11 | University Of Florida Research Foundation | METHODS AND COMPOSITIONS FOR ENHANCED COMFORT CONTACT LENS |
| US12083099B2 (en) | 2020-10-28 | 2024-09-10 | Accencio LLC | Methods of treating symptoms of coronavirus infection with viral protease inhibitors |
Family Cites Families (68)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5008294A (en) * | 1985-02-11 | 1991-04-16 | Chemex Pharmaceuticals, Inc. | Methods of treating tumors with compositions of catecholic butanes |
| CA1283906C (en) * | 1983-05-09 | 1991-05-07 | Makoto Sunagawa | .beta.-LACTAM COMPOUNDS AND PRODUCTION THEREOF |
| GB8929070D0 (en) * | 1989-12-22 | 1990-02-28 | Fujisawa Pharmaceutical Co | Peptide compounds,processes for preparation thereof and pharmaceutical composition comprising the same |
| US5340801A (en) * | 1991-05-08 | 1994-08-23 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Compounds having cholecystokinin and gastrin antagonistic properties |
| US5409690A (en) * | 1993-06-23 | 1995-04-25 | Chemex Pharmaceuticals, Inc. | Treatment of multidrug resistant diseases in cancer cell by potentiating with masoprocol |
| US6900238B1 (en) * | 1995-12-07 | 2005-05-31 | The Scripps Research Institute | HIV protease inhibitors |
| KR100509388B1 (ko) | 1996-10-18 | 2005-08-23 | 버텍스 파마슈티칼스 인코포레이티드 | 세린 프로테아제, 특히 간염 ｃ 바이러스 ｎｓ３ 프로테아제의 저해제 |
| ES2234144T3 (es) | 1997-08-11 | 2005-06-16 | Boehringer Ingelheim (Canada) Ltd. | Analogos de peptidos inhibidores de la hepatitis c. |
| WO1999007733A2 (en) | 1997-08-11 | 1999-02-18 | Boehringer Ingelheim (Canada) Ltd. | Hepatitis c inhibitor peptides |
| WO1999051613A1 (en) | 1998-04-03 | 1999-10-14 | Medivir Ab | Prodrugs of phosphorous-containing pharmaceuticals |
| JPH11292840A (ja) * | 1998-04-06 | 1999-10-26 | Soyaku Gijutsu Kenkyusho:Kk | ノルスタチン誘導体又はその塩 |
| US6639053B1 (en) | 1998-06-24 | 2003-10-28 | Tetsuya Toyoda | HCV-derived RNA polymerase gene |
| AR022061A1 (es) | 1998-08-10 | 2002-09-04 | Boehringer Ingelheim Ca Ltd | Peptidos inhibidores de la hepatitis c, una composicion farmaceutica que los contiene, el uso de los mismos para preparar una composicion farmaceutica, el uso de un producto intermedio para la preparacion de estos peptidos y un procedimiento para la preparacion de un peptido analogo de los mismos. |
| US6323180B1 (en) * | 1998-08-10 | 2001-11-27 | Boehringer Ingelheim (Canada) Ltd | Hepatitis C inhibitor tri-peptides |
| DE19915178A1 (de) | 1999-04-03 | 2000-10-05 | Univ Mainz Johannes Gutenberg | Hepatitis C Virus Zellkultursystem |
| UA74546C2 (en) * | 1999-04-06 | 2006-01-16 | Boehringer Ingelheim Ca Ltd | Macrocyclic peptides having activity relative to hepatitis c virus, a pharmaceutical composition and use of the pharmaceutical composition |
| GB9925955D0 (en) * | 1999-11-02 | 1999-12-29 | Angeletti P Ist Richerche Bio | Hcv n33 protease inhibitors |
| JP2003526634A (ja) * | 1999-12-03 | 2003-09-09 | ブリストル−マイヤーズ スクイブ ファーマ カンパニー | Ｃ型肝炎ウイルスＮＳ３プロテアーゼのα−ケトアミド阻害剤 |
| ES2240446T3 (es) | 2000-04-03 | 2005-10-16 | Vertex Pharma | Inhibidores de serina proteasas, particularmente la proteasa ns3 del virus de la hepatitis c. |
| AR029903A1 (es) * | 2000-04-05 | 2003-07-23 | Schering Corp | Inhibidores macrociclicos de la ns3-serina proteasa, del virus de la hepatitis c, que comprenden partes p2 n-ciclicas, composiciones farmaceuticas y utilizacion de los mismos para la manufactura de un medicamento |
| DK1385870T3 (da) * | 2000-07-21 | 2010-07-05 | Schering Corp | Peptider som inhibitorer af NS3-serinprotease fra hepatitis C-virus |
| AR034127A1 (es) | 2000-07-21 | 2004-02-04 | Schering Corp | Imidazolidinonas como inhibidores de ns3-serina proteasa del virus de hepatitis c, composicion farmaceutica, un metodo para su preparacion, y el uso de las mismas para la manufactura de un medicamento |
| US7244721B2 (en) | 2000-07-21 | 2007-07-17 | Schering Corporation | Peptides as NS3-serine protease inhibitors of hepatitis C virus |
| DE60119968T2 (de) | 2000-11-20 | 2007-01-18 | Bristol-Myers Squibb Co. | Hepatitis c tripeptid inhibitoren |
| KR20030091946A (ko) * | 2000-12-12 | 2003-12-03 | 쉐링 코포레이션 | Ｃ형 간염 바이러스의 ｎｓ3-세린 프로테아제억제제로서의 디아릴 펩티드 |
| CA2449504A1 (en) * | 2001-07-11 | 2003-01-23 | Vertex Pharmaceuticals Incorporated | Bridged bicyclic serine protease inhibitors |
| US7241796B2 (en) | 2001-10-24 | 2007-07-10 | Vertex Pharmaceuticals Inc. | Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| US6867185B2 (en) | 2001-12-20 | 2005-03-15 | Bristol-Myers Squibb Company | Inhibitors of hepatitis C virus |
| US6894072B2 (en) | 2002-01-23 | 2005-05-17 | Schering Corporation | Compounds as NS3-serine protease inhibitors of hepatitis C virus |
| CA2369711A1 (en) | 2002-01-30 | 2003-07-30 | Boehringer Ingelheim (Canada) Ltd. | Macrocyclic peptides active against the hepatitis c virus |
| CA2370396A1 (en) | 2002-02-01 | 2003-08-01 | Boehringer Ingelheim (Canada) Ltd. | Hepatitis c inhibitor tri-peptides |
| CA2369970A1 (en) | 2002-02-01 | 2003-08-01 | Boehringer Ingelheim (Canada) Ltd. | Hepatitis c inhibitor tri-peptides |
| US7091184B2 (en) * | 2002-02-01 | 2006-08-15 | Boehringer Ingelheim International Gmbh | Hepatitis C inhibitor tri-peptides |
| US6828301B2 (en) | 2002-02-07 | 2004-12-07 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions for hepatitis C viral protease inhibitors |
| KR20040099425A (ko) | 2002-04-11 | 2004-11-26 | 버텍스 파마슈티칼스 인코포레이티드 | 세린 프로테아제, 특히 ｃ형 간염 바이러스 ｎｓ3-ｎｓ4프로테아제의 억제제 |
| JP4312711B2 (ja) | 2002-05-20 | 2009-08-12 | ブリストル−マイヤーズ スクイブ カンパニー | ヘテロ環式スルホンアミドｃ型肝炎ウイルス阻害剤 |
| WO2004032827A2 (en) | 2002-05-20 | 2004-04-22 | Bristol-Myers Squibb Company | Hepatitis c virus inhibitors |
| MY140680A (en) | 2002-05-20 | 2010-01-15 | Bristol Myers Squibb Co | Hepatitis c virus inhibitors |
| JP4271148B2 (ja) | 2002-05-20 | 2009-06-03 | ブリストル−マイヤーズ スクイブ カンパニー | 置換シクロアルキルｐ１’ｃ型肝炎ウイルスインヒビター |
| JP2005531638A (ja) * | 2002-07-01 | 2005-10-20 | ファルマシア・アンド・アップジョン・カンパニー・エルエルシー | Ｈｃｖｎｓ５ｂポリメラーゼ阻害剤 |
| US20040033959A1 (en) | 2002-07-19 | 2004-02-19 | Boehringer Ingelheim Pharmaceuticals, Inc. | Pharmaceutical compositions for hepatitis C viral protease inhibitors |
| WO2004026896A2 (en) | 2002-09-23 | 2004-04-01 | Medivir Ab | Hcv ns-3 serine protease inhibitors |
| EP1408031A1 (en) * | 2002-10-09 | 2004-04-14 | 3 D Gene Pharma | Pyrolidine derivatives useful in treatment of hepatitis C virus infection |
| US20050075279A1 (en) | 2002-10-25 | 2005-04-07 | Boehringer Ingelheim International Gmbh | Macrocyclic peptides active against the hepatitis C virus |
| CA2498653C (en) | 2002-10-29 | 2010-12-14 | Boehringer Ingelheim International Gmbh | Inhibitor-resistant hcv ns3 protease |
| US20050159345A1 (en) | 2002-10-29 | 2005-07-21 | Boehringer Ingelheim International Gmbh | Composition for the treatment of infection by Flaviviridae viruses |
| CA2515216A1 (en) | 2003-02-07 | 2004-08-26 | Enanta Pharmaceuticals, Inc. | Macrocyclic hepatitis c serine protease inhibitors |
| US6908901B2 (en) | 2003-03-05 | 2005-06-21 | Boehringer Ingelheim International, Gmbh | Hepatitis C inhibitor peptide analogs |
| EP1613353A1 (en) | 2003-04-02 | 2006-01-11 | Boehringer Ingelheim International GmbH | Pharmaceutical compositions for hepatitis c viral protease inhibitors |
| WO2004092161A1 (en) | 2003-04-11 | 2004-10-28 | Vertex Pharmaceuticals Incorporated | Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| JP4733023B2 (ja) | 2003-04-16 | 2011-07-27 | ブリストル−マイヤーズ スクイブ カンパニー | Ｃ型肝炎ウイルスの大環状イソキノリンペプチド阻害剤 |
| KR101031825B1 (ko) | 2003-04-18 | 2011-04-29 | 이난타 파마슈티칼스, 인코포레이티드 | 거대고리형 퀴녹살리닐 ｃ형 간염 세린 단백질분해효소억제제 |
| CL2004001161A1 (es) | 2003-05-21 | 2005-04-08 | Boehringer Ingelheim Int | Compuestos describe compuestos derivados de quinolina; composicion farmaceutica; y su uso para tratar una enfermedad causada por el virus de la hepatitis c. |
| WO2004113365A2 (en) | 2003-06-05 | 2004-12-29 | Enanta Pharmaceuticals, Inc. | Hepatitis c serine protease tri-peptide inhibitors |
| US7125845B2 (en) * | 2003-07-03 | 2006-10-24 | Enanta Pharmaceuticals, Inc. | Aza-peptide macrocyclic hepatitis C serine protease inhibitors |
| WO2005037826A1 (en) * | 2003-10-17 | 2005-04-28 | Incyte Corporation | Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases |
| JP4902361B2 (ja) | 2004-01-30 | 2012-03-21 | メディヴィル・アクチエボラーグ | Ｈｃｖｎｓ−３セリンプロテアーゼインヒビター |
| PE20070211A1 (es) | 2005-07-29 | 2007-05-12 | Medivir Ab | Compuestos macrociclicos como inhibidores del virus de hepatitis c |
| WO2007014922A1 (en) | 2005-07-29 | 2007-02-08 | Tibotec Pharmaceuticals Ltd. | Macrocyclic inhibitors of hepatitis c virus |
| JP5230416B2 (ja) | 2005-07-29 | 2013-07-10 | テイボテク・フアーマシユーチカルズ | Ｃ型肝炎ウイルスの大員環状阻害剤 |
| TWI393723B (zh) | 2005-07-29 | 2013-04-21 | Tibotec Pharm Ltd | Ｃ型肝炎病毒之大環抑制劑（九） |
| CN101273042B (zh) | 2005-07-29 | 2013-11-06 | 泰博特克药品有限公司 | 丙型肝炎病毒的大环抑制剂 |
| PE20070210A1 (es) | 2005-07-29 | 2007-04-16 | Tibotec Pharm Ltd | Compuestos macrociclicos como inhibidores del virus de hepatitis c |
| ES2373685T3 (es) | 2005-07-29 | 2012-02-07 | Tibotec Pharmaceuticals | Inhibidores macrocíclicos del virus de la hepatitis c. |
| CA2617099C (en) | 2005-07-29 | 2014-03-25 | Tibotec Pharmaceuticals Ltd. | Macrocyclic inhibitors of hepatitis c virus |
| JO2768B1 (en) | 2005-07-29 | 2014-03-15 | تيبوتيك فارماسيوتيكالز ليمتد | Large cyclic inhibitors of hepatitis C virus |
| US7700552B2 (en) | 2005-07-29 | 2010-04-20 | Medivir Ab | Macrocyclic inhibitors of hepatitis C virus |
| PE20070343A1 (es) | 2005-07-29 | 2007-05-12 | Medivir Ab | Inhibidores macrociclicos del virus de la hepatitis c |
-
2005
- 2005-01-28 JP JP2006551001A patent/JP4902361B2/ja not_active Expired - Fee Related
- 2005-01-28 EP EP05704764A patent/EP1713822B1/en not_active Expired - Lifetime
- 2005-01-28 SI SI200530899T patent/SI1713823T1/sl unknown
- 2005-01-28 WO PCT/SE2005/000097 patent/WO2005073195A2/en not_active Ceased
- 2005-01-28 UA UAA200608624A patent/UA84050C2/ru unknown
- 2005-01-28 MY MYPI20050349 patent/MY153011A/en unknown
- 2005-01-28 US US10/572,349 patent/US7671032B2/en active Active
- 2005-01-28 PL PL05704765T patent/PL1713823T3/pl unknown
- 2005-01-28 PL PL05704764T patent/PL1713822T3/pl unknown
- 2005-01-28 AT AT05704765T patent/ATE448243T1/de active
- 2005-01-28 DK DK05704764.9T patent/DK1713822T3/da active
- 2005-01-28 CA CA2552319A patent/CA2552319C/en not_active Expired - Fee Related
- 2005-01-28 NZ NZ548740A patent/NZ548740A/en not_active IP Right Cessation
- 2005-01-28 CA CA2552317A patent/CA2552317C/en not_active Expired - Fee Related
- 2005-01-28 ES ES05704765T patent/ES2336009T3/es not_active Expired - Lifetime
- 2005-01-28 US US10/572,418 patent/US7608590B2/en not_active Expired - Fee Related
- 2005-01-28 AR ARP050100340A patent/AR048401A1/es not_active Application Discontinuation
- 2005-01-28 DE DE602005017582T patent/DE602005017582D1/de not_active Expired - Lifetime
- 2005-01-28 WO PCT/SE2005/000096 patent/WO2005073216A2/en not_active Ceased
- 2005-01-28 PT PT05704765T patent/PT1713823E/pt unknown
- 2005-01-28 ES ES05704764T patent/ES2342944T3/es not_active Expired - Lifetime
- 2005-01-28 DE DE602005019979T patent/DE602005019979D1/de not_active Expired - Lifetime
- 2005-01-28 EP EP05704765A patent/EP1713823B1/en not_active Expired - Lifetime
- 2005-01-28 AT AT05704764T patent/ATE461209T1/de not_active IP Right Cessation
- 2005-01-28 TW TW094102697A patent/TWI361195B/zh not_active IP Right Cessation
- 2005-01-28 KR KR1020127011467A patent/KR20120090077A/ko not_active Ceased
- 2005-01-28 BR BRPI0506948A patent/BRPI0506948B1/pt not_active IP Right Cessation
- 2005-01-28 MY MYPI20050347A patent/MY146349A/en unknown
- 2005-01-28 AR ARP050100341A patent/AR047793A1/es not_active Application Discontinuation
- 2005-01-28 EA EA200601399A patent/EA012410B1/ru not_active IP Right Cessation
- 2005-01-28 BR BRPI0506945-9A patent/BRPI0506945A/pt not_active Application Discontinuation
- 2005-01-28 DK DK05704765.6T patent/DK1713823T3/da active
- 2005-01-28 NZ NZ548739A patent/NZ548739A/en not_active IP Right Cessation
- 2005-01-28 HR HR20100048T patent/HRP20100048T1/hr unknown
- 2005-01-28 UA UAA200608686A patent/UA84189C2/ru unknown
- 2005-01-28 TW TW094102721A patent/TWI367211B/zh not_active IP Right Cessation
- 2005-01-28 RS RSP-2010/0036A patent/RS51243B/sr unknown
- 2005-01-28 AU AU2005207815A patent/AU2005207815B2/en not_active Ceased
- 2005-01-28 KR KR1020067017480A patent/KR101159575B1/ko not_active Expired - Fee Related
- 2005-01-28 AU AU2005207816A patent/AU2005207816C1/en not_active Ceased
- 2005-01-28 EA EA200601400A patent/EA014584B1/ru not_active IP Right Cessation
- 2005-01-28 JP JP2006551000A patent/JP5248783B2/ja not_active Expired - Fee Related
-
2006
- 2006-07-13 IL IL176848A patent/IL176848A/en not_active IP Right Cessation
- 2006-07-18 IL IL176921A patent/IL176921A/en active Protection Beyond IP Right Term
- 2006-07-24 EC EC2006006725A patent/ECSP066725A/es unknown
- 2006-07-24 EC EC2006006726A patent/ECSP066726A/es unknown
- 2006-07-28 CR CR8539A patent/CR8539A/es not_active Application Discontinuation
- 2006-07-28 NI NI200600168A patent/NI200600168A/es unknown
- 2006-07-28 CR CR8540A patent/CR8540A/es not_active Application Discontinuation
- 2006-08-23 KR KR1020067016960A patent/KR101217036B1/ko not_active Expired - Fee Related
- 2006-08-29 ZA ZA2006/07214A patent/ZA200607214B/en unknown
- 2006-08-29 NO NO20063851A patent/NO341392B1/no not_active IP Right Cessation
-
2009
- 2009-09-11 US US12/557,638 patent/US20100003216A1/en not_active Abandoned
- 2009-12-21 US US12/642,984 patent/US20100166706A1/en not_active Abandoned
-
2010
- 2010-02-10 CY CY20101100134T patent/CY1109779T1/el unknown
- 2010-12-15 JP JP2010279178A patent/JP2011140488A/ja active Pending
-
2013
- 2013-11-12 JP JP2013234011A patent/JP5795619B2/ja not_active Expired - Fee Related
-
2014
- 2014-11-11 LU LU92595C patent/LU92595I2/xx unknown
- 2014-11-12 NL NL300703C patent/NL300703I2/nl unknown
-
2017
- 2017-03-27 US US15/470,599 patent/US10172846B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007524670A5 (https=) | ||
| RU2436787C2 (ru) | Макроциклические ингибиторы вируса гепатита с | |
| JP5377290B2 (ja) | 抗ウイルス剤としての大環状化合物 | |
| CA2617099C (en) | Macrocyclic inhibitors of hepatitis c virus | |
| JP2008509218A5 (https=) | ||
| AU2008212760B2 (en) | HCV inhibiting macrocyclic phenylcarbamates | |
| JP2011511841A5 (https=) | ||
| JP2014503516A5 (https=) | ||
| JP2013523765A5 (https=) | ||
| JP2007515405A5 (https=) | ||
| JP2007535491A5 (https=) | ||
| CA2536436A1 (en) | 2-amido-4-aryloxy-1-carbonyl pyrrolidine derivatives as inhibitors of serine proteases, particularly hcv ns3-ns4a protease | |
| JP2007534636A5 (https=) | ||
| JP2008530096A5 (https=) | ||
| JP2013521279A5 (https=) | ||
| RU2008152171A (ru) | Новые ингибиторы вирусной репликации гепатита с | |
| US20090060874A1 (en) | Bicyclic pyrrolidine derivatives | |
| NO342393B1 (no) | Makrocykliske inhibitorer av hepatitt C virus | |
| CN110684067A (zh) | 取代的核苷和核苷酸 | |
| US20220081444A1 (en) | 6,7-dihydro-4h-pyrazolo[1,5-a]pyrazine indole-2-carboxamides active against the hepatitis b virus (hbv) | |
| JP2011523651A5 (https=) | ||
| EA014646B1 (ru) | Макроциклические ингибиторы вируса гепатита с | |
| JP2012520288A (ja) | ピラゾロ［１，５−ａ］−１，３，５−トリアジン誘導体、その調製、及びその治療的使用方法 | |
| US20210355129A1 (en) | Novel urea 6,7-dihydro-4h-pyrazolo[1,5-a]pyrazines active against the hepatitis b virus (hbv) | |
| AU2005298923A1 (en) | MIF-inhibitors |